Stockscreener 앱 받기
0.0127
10.43%
0.0012
T 2 Biosystems Inc 주식(TTOO)의 최신 뉴스
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50-Day Moving Average – What’s Next? - Defense World
Stocks in play: Microbix Biosystems Inc. - The Globe and Mail
T2 Biosystems Inc. (TTOO) Stock Price | Live Quotes & Charts | OTO - StocksToTrade
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50 Day Moving Average – What’s Next? - Defense World
Tangible book value per share of T2 Biosystems, Inc. – LSE:0A57 - TradingView
Ocean Dx sepsis test matches gold standard in early study - BioWorld MedTech
TTOO Interactive Stock Chart | T2 Biosystems, Inc. Stock - Yahoo Finance
T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis Report - Yahoo Finance
Why retail investors favor Rapid Micro Biosystems Inc. stock2025 Trading Volume Trends & Low Risk Entry Point Tips - nchmf.gov.vn
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
GBS (NYSE:GBS) versus T2 Biosystems (NASDAQ:TTOO) Head-To-Head Survey - Defense World
Contestants Turn in a Terrific Short Selling Performance - TradingView
Reviewing T2 Biosystems (NASDAQ:TTOO) & Titan Medical (NASDAQ:TMDIF) - Defense World
Revenue per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
EBIT per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway - Investing News Network
Lyme Disease Pipeline 2025: In-Depth Clinical Trials Analysis And Emerging Therapies Report By Delveinsight Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Menafn.com
Reviewing Titan Medical (NASDAQ:TMDIF) and T2 Biosystems (NASDAQ:TTOO) - Defense World
Sepsis Diagnostics Market Poised for Remarkable Expansion by 2035, Reveals Prophecy Market Insights Study - newstrail.com
Will Retractable Technologies Inc. outperform the marketJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
T2 Biosystems, Inc. (NASDAQ:TTOO) Sees Significant Drop in Short Interest - Defense World
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates - MSN
Rapid Micro Biosystems Reports 15% Recurring Revenue Growth, Lands Major $45M Financing Deal - Stock Titan
Apyx Medical Strengthens Global Sales Leadership with Strategic Hires as New AYON System Launches - Stock Titan
Short Interest in T2 Biosystems, Inc. (NASDAQ:TTOO) Expands By 1,146.7% - Defense World
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells - Nature
Rapid Micro: Lake Street initiates coverage with Buy rating, PT $8. - AInvest
T2 Biosystems (NASDAQ:TTOO) versus InspireMD (NYSE:NSPR) Financial Review - Defense World
What analysts say about Rapid Micro Biosystems Inc. stockUnmatched profit potential - Autocar Professional
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Does Rapid Micro Biosystems Inc. stock pay reliable dividends200 Percent Profit Outlook - beatles.ru
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming Earnings Reports and Analyst Ratings Actions - AInvest
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - simplywall.st
Microbix Biosystems Leads These 3 TSX Penny Stocks To Watch - simplywall.st
Rapid Micro Biosystems, Inc. (RPID): Among the Hot Penny Stocks to Buy Now - Yahoo Finance
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Balance Sheet – OTC:TTOO - TradingView
TTOO Stock Price and Chart — OTC:TTOO - TradingView
Epicore Biosystems scores $26M to expand sweat-sensing wearable technology - Mobi Health News
T2 Biosystems to be delisted from Nasdaq - MSN
Sepsis Therapeutics Market Size | Industry Report, 2030 - Grand View Research
T2 Biosystems stock plunges to 52-week low of $0.25 - MSN
T2 Biosystems amends loan terms, extends maturity date - Investing.com
TTOO Stock Forecast: T2, A Zero To Hero Or No Hope For Buyers? - The Market Periodical
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
T2 Biosystems announces board changes and incentive plan approval - Investing.com
T2 Biosystems Enhances Governance and Leadership Stability - TipRanks
Competition ticks up to reset the clock for sepsis - BioWorld MedTech
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor - citybiz
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally - Yahoo Finance
T2 Biosystems extends Vizient supplier agreement By Investing.com - Investing.com UK
T2 Biosystems faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
T2 Biosystems faces Nasdaq delisting over share price - Investing.com
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens - SelectScience
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - Yahoo Finance
The Reason for Resonance: Using T2MR to Advance the Diagnosis of Bloodstream Infections - Labroots
T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com UK
2.49%
자본화:
|
볼륨(24시간):